Completed

GENEVAX-HIV Vaccine Dose Escalation Study in HIV Seronegative Volunteers

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

APL 400-003

Biological
Who is being recruted

Blood-Borne Infections+11

+ Urogenital Diseases

+ Genital Diseases

From 18 to 60 Years
+14 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Phase 1
Interventional
See protocol details

Summary

Principal SponsorWyeth-Lederle Vaccines
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner

In this open-label study, volunteers are given an intramuscular injection of GENEVAX-HIV vaccine using the Biojector 2000. Safety measures and immune response are assessed accordingly.

NCT00002231
Principal SponsorWyeth-Lederle Vaccines
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 60 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Blood-Borne InfectionsUrogenital DiseasesGenital DiseasesCommunicable DiseasesImmunologic Deficiency SyndromesImmune System DiseasesInfectionsRetroviridae InfectionsRNA Virus InfectionsSexually Transmitted DiseasesVirus DiseasesSexually Transmitted Diseases, ViralLentivirus InfectionsHIV Infections

Criteria

4 inclusion criteria required to participate
Agree to use effective methods of birth control during the study

Are 18 - 60 years old

Are HIV-negative and in good health

Are able to understand how infections such as HIV are spread

10 exclusion criteria prevent from participating
Abuse alcohol or drugs or have an uncontrolled psychiatric disorder

Are allergic to bupivacaine, vaccines, or certain local anesthetics

Are pregnant or breast-feeding

Have an immune system disorder or have received therapy for an immune system disorder

Show More Criteria

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Univ of Pennsylvania Med Ctr

Philadelphia, United StatesOpen Univ of Pennsylvania Med Ctr in Google Maps
CompletedOne Study Center